LL-37
A germ-fighting peptide your body makes. Lab-made LL-37 is not approved, and a bigger study found it did not help wounds heal.

Not approved in the US. Taken off the FDA Category 2 list in April 2026, but not approved.
A small trial looked hopeful. A bigger one found no overall benefit.
About 200 people, all treated on the skin, not by shot.
Three separate grades: the law (not approved), proof (mixed, mostly negative), and safety data (only for skin use). Skin data says nothing about shots.
By the Peptide Science Desk Editorial TeamFact-checked against FDA and official sources · Not yet reviewed by a licensed clinician. How we check facts
What is it?
LL-37 is a 37-building-block peptide your own body makes. White blood cells and skin make it to punch holes in germs. Its name comes from its first two building blocks (two leucines, "LL") and its length. The LL-37 sold online is made in a lab.
Why do people use it?
Online, people use it hoping to fight long infections, heal wounds or calm the gut. In science, it was mostly tested as a cream or solution put right on stubborn skin sores.
Does it really work?
Not proven. On leg sores, a small trial looked hopeful, but a bigger 148-person trial found no overall benefit. A small foot ulcer study saw better new tissue but did not lower germs or swelling markers. We found no trial of LL-37 shots for infections or the gut.
Studies in people
Only 3 small human treatment studies found, all on skin sores. None tested shots.
| Study design | People | What they measured | What they found | Year | Journal | PubMed |
|---|---|---|---|---|---|---|
| Randomized, placebo | 34 adults with leg ulcers | Healing over 4 weeks | The 2 lower strengths healed faster. The highest was no better than placebo. | 2014 | Wound Repair Regen | PMID 25041740 |
| Randomized, placebo (phase 2b) | 148 adults with leg ulcers | Healing | No better than placebo overall. A subgroup with big sores looked better, but that needs a new test. | 2021 | Wound Repair Regen | PMID 34687253 |
| Randomized, placebo, cream | Adults with diabetic foot sores (number not given in the summary) | Healing, swelling markers, germs | More healthy new tissue. Swelling markers and germ counts were not clearly better. | 2023 | Arch Dermatol Res | PMID 37480520 |
Is it safe? Side effects
- The FDA says it does not have enough safety facts about LL-37 in people.
- The FDA says lab and animal research suggests LL-37 may hurt male fertility and may help tumors grow in some body parts.
- A foot sore study did not show clearly fewer germs, so "germ-killing" claims are not proven in people.
- Shots sold online were never tested in people.
Is it legal in the US?
LL-37 is not an FDA-approved medicine.
- The FDA had put LL-37 on its "Category 2" list of risky pharmacy ingredients.
- In April 2026, it was moved off that list because the groups that asked about it withdrew their request. The FDA did not say it is safe.
- It is also not on the list regular pharmacies may use.
- On October 28, 2026, HHS issued a peptide policy for 6 other peptides. It does not cover LL-37.
What this means for LL-37
Banned in sports? Drug tests
Not named, but may be banned.
LL-37 is not named on WADA's list. But WADA says its list is not complete. It also bans any drug that is not approved for people by any government anywhere (section S0). From Jan 1, 2027, that rule names "peptides" too. Ask USADA before you use it.
Talk to your doctor
If you have a wound that will not heal or an infection that keeps coming back, see a doctor. These need a real cause found, like poor blood flow or diabetes. We never share doses or tell you where to buy. Print our doctor questions sheet.
More questions
Is LL-37 natural?
Yes. Your body makes LL-37. It is part of your built-in germ defense.
Is LL-37 FDA approved?
No. It is not an FDA-approved medicine.
Does LL-37 help acne?
We found no good trial in people that tested this.
Related peptides
- BPC-157Not approved · Proof: Early
- KPVNot approved · Proof: Animal or lab only
- Thymosin alpha-1Not approved · Proof: Mixed
- ARA-290 (cibinetide)Not approved · Proof: Early
Guides and tools
- FDA Category 2 Peptide List (2026): Which Peptides Are on It Now?Guide
- Can peptides cause cancer? What doctors actually knowGuide
- Drug test & sports ban checkerTool
- Compare LL-37 with another peptideTool
- Is my peptide source legit?Tool
- FDA warning letters trackerTool
Sources
- FDA: Bulk drug substances that may present significant safety risks
- FDA: Bulk drug substances nominated for 503A compounding (category lists, updated May 14, 2026)
- PubMed: Mahlapuu et al., LL-37 for hard-to-heal venous leg ulcers, phase 2b trial, Wound Repair Regen 2021
- PubMed: Grönberg et al., LL-37 for venous leg ulcers, Wound Repair Regen 2014
- FDA: Compounding and the FDA, Questions and Answers
- HHS: Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances (Oct 28, 2026)
- Federal Register (public inspection): FR Doc. 2026-22192, HHS peptide compounding policy